Previous 10 | Next 10 |
TC Biopharm press release ( NASDAQ: TCBP ): 1H GAAP EPS of $1.13. Revenue of $1.2M. Cash and cash equivalents were £6.0 million or $7.3 million as of June 30, 2022 compared to £1.6 million as of December 31, 2021. For further details see: TC Biopharm GAAP E...
TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update PR Newswire Dosed first three patients within Phase 2b clinical trial of OmnImmune®, an allogeneic unmodified cell therapy focused on treating Acute Myeloid Leukemia (AML). ...
TC BioPharm Announces Closing of $7.35 Million Private Placement PR Newswire EDINBURGH, Scotland , Nov. 30, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company dev...
TC BioPharm Announces $7.35 Million Private Placement PR Newswire EDINBURGH, Scotland , Nov. 28, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company d...
TC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune®, in Patients with Acute Myeloid Leukemia PR Newswire 3 Patients Dosed in 5 Patient Safety Cohort EDINBURGH, Scotland , Nov. 22, 2022 /PRNewswire/ -...
TC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise PR Newswire SAB selected to advance new therapeutic trials and strategic partnerships EDINBURGH, Scotland , Oct. 26, 2022 /PRNewswire/ -- TC Bi...
TC BioPharm to Present at Upcoming Investor Conferences PR Newswire EDINBURGH, Scotland , Oct. 3, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company devel...
TC BioPharm Receives MHRA Approval for 18-Month Extrapolated Shelf-Life of Allogeneic Cell Therapy Product, OmnImmune® PR Newswire EDINBURGH, Scotland , Sept. 13, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDA...
TC BioPharm to Present at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire EDINBURGH, Scotland , Aug. 22, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical s...
TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit PR Newswire Event Taking Place in Boston on July 26-28, 2022 EDINBURGH, Scotland , July 25, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Co...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
TC BioPharm (Holdings) plc Website:
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia PR Newswire 5 patients treated in "safety cohort" showed no drug related Serious Adverse Events Restart of trial after amendment approved by MHRA to increase dose level ...
TCBP Announces Launch of Compassionate Use Program for TCB008 PR Newswire The Company's lead therapeutic will be available through a newly opened compassionate use program EDINBURGH, Scotland , May 15, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
2024-05-07 06:02:00 ET 3 Tips for Buying and Selling Penny Stocks During After Hours Trading penny stocks during after-hours sessions offers unique opportunities for investors seeking to capitalize on market movements outside of standard trading hours. Penny stocks , typically price...